Page last updated: 2024-11-07

carbachol and Degenerative Diseases, Central Nervous System

carbachol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marino, MJ1
Rouse, ST1
Levey, AI1
Potter, LT1
Conn, PJ1
Sherer, TB1
Trimmer, PA1
Parks, JK1
Tuttle, JB1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Muscarinic M1 Receptor Availability and Cognition in Schizophrenia[NCT05105542]Phase 218 participants (Anticipated)Interventional2021-04-20Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for carbachol and Degenerative Diseases, Central Nervous System

ArticleYear
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, Sep-15, Volume: 95, Issue:19

    Topics: Animals; Carbachol; Elapid Venoms; Electrophysiology; Hippocampus; Male; Microscopy, Immunoelectron;

1998
Mitochondrial DNA-depleted neuroblastoma (Rho degrees) cells exhibit altered calcium signaling.
    Biochimica et biophysica acta, 2000, Apr-17, Volume: 1496, Issue:2-3

    Topics: Calcium; Calcium Signaling; Carbachol; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cytologic

2000